Drug:
Reaction: PNEUMONIA
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555299 |
CA |
65 | 1 |
Pneumonia, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
| 2 | 26555301 |
26 | ||
Pneumonia, Influenza, |
||||
ISOTRETINOIN, |
||||
| 3 | 26555345 |
US |
1 | |
Pneumonia, Chronic obstructive pulmonary disease, Hypertension, Chronic kidney disease, Hepatic cirrhosis, |
||||
RISANKIZUMAB-RZAA, |
||||
| 4 | 26555350 |
JP |
89 | 2 |
Pneumonia, Blood pressure fluctuation, |
||||
SACUBITRIL AND VALSARTAN, |
||||
| 5 | 26555394 |
TH |
||
Pneumonia, Product contamination physical, |
||||
| 6 | 26555431 |
US |
1 | |
Pneumonia, |
||||
TREPROSTINIL, TREPROSTINIL, PANTOPRAZOLE SODIUM, SILDENAFIL CITRATE, BUMETANIDE, ROSUVASTATIN CALCIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TIZANIDINE HYDROCHLORIDE, OXYGEN, 0XYGEN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 7 | 26555458 |
US |
71 | 1 |
Loss of consciousness, Pneumonia, Oxygen saturation decreased, Lung hyperinflation, |
||||
UPADACITINIB, |
||||
| 8 | 26555722 |
AU |
2 | |
Pneumonia, Toxicity to various agents, Accident, Drug interaction, |
||||
TAPENTADOL HYDROCHLORIDE, FENTANYL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DOXYLAMINE SUCCINATE, OLANZAPINE, PREGABALIN, SERTRALINE HYDROCHLORIDE, |
||||
| 9 | 26555771 |
EU |
63 | 2 |
Streptococcal sepsis, Purulent pericarditis, Cardiac tamponade, Pneumonia, Multiple organ dysfunction syndrome, |
||||
OCRELIZUMAB, |
||||
| 10 | 26555786 |
US |
76 | 1 |
Hypoxia, Pneumonia, |
||||
LENALIDOMIDE, LENALIDOMIDE, ALBUTEROL SULFATE, ALPRAZOLAM, AMLODIPINE BESYLATE, FERROUS SULFATE, LANSOPRAZOLE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LORAZEPAM, METHOCARBAMOL, MIRTAZAPINE, MONTELUKAST SODIUM, OMEPRAZOLE MAGNESIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, |
||||
| 11 | 26555960 |
CA |
65 | 2 |
Pneumonia, Vomiting, Asthma, Dyspnoea, Oedema, Wheezing, Drug hypersensitivity, |
||||
FLUTICASONE PROPIONATE, AMINOPHYLLINE, AMLODIPINE BESYLATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, HYDROMORPHONE HYDROCHLORIDE, OMALIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 12 | 26556031 |
SG |
72 | 2 |
Death, Dyspnoea, Pneumonia, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 13 | 26556203 |
US |
||
Pneumonia, Central venous catheterisation, Discomfort, Autoscopy, |
||||
AZELASTINE, BUPROPION HYDROCHLORIDE, FAMOTIDINE, MINOXIDIL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, PROGESTERONE, CETIRIZINE HYDROCHLORIDE, BRENSOCATIB, MEPOLIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, SIMVASTATIN, LOSARTAN POTASSIUM, LOSARTAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 14 | 26556260 |
US |
18 | |
Pneumonia, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CLARITHROMYCIN, BACLOFEN, FAMOTIDINE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, GABAPENTIN, |
||||
| 15 | 26556286 |
CA |
76 | |
Pneumonia, Osteomyelitis, Intentional product use issue, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, |
||||
| 16 | 26556364 |
CA |
72 | |
Pneumonia, |
||||
INFLIXIMAB, INFLIXIMAB-DYYB, PREDNISONE, |
||||
| 17 | 26556393 |
JP |
1 | |
Sputum retention, Injection site erythema, Injection site induration, COVID-19, Insomnia, Pneumonia, Restlessness, Pneumonia, Epilepsy, |
||||
LEUPROLIDE ACETATE, CELECOXIB, LANSOPRAZOLE, MAGNESIUM OXIDE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, CEFAZOLIN SODIUM, REMDESIVIR, REMDESIVIR, |
||||
| 18 | 26556486 |
CA |
40 | 2 |
Abdominal distension, Adverse reaction, Back injury, Bursitis, Coeliac disease, Condition aggravated, Dyspepsia, Fall, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, Grip strength decreased, Headache, Hepatitis, Hypoaesthesia, Injury, Insomnia, Intentional product use issue, Liver function test increased, Malaise, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Neck pain, Off label use, Pain in extremity, Pneumonia, Product label confusion, Weight increased, Wheezing, Wound infection, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 19 | 26556567 |
IL |
13 | 2 |
Immune thrombocytopenia, Obesity, Immune system disorder, Pneumonia, Pneumonia, Maternal exposure before pregnancy, Unwanted pregnancy, Illness, Hepatic function abnormal, Cholecystitis, Poor dental condition, Hypersensitivity, Abdominal pain lower, Vaccination site pain, Dizziness, Heavy menstrual bleeding, Oropharyngeal pain, Urinary tract infection, Pancreatitis, Anxiety, Depression, Intermenstrual bleeding, Hormone level abnormal, Iron deficiency anaemia, Uterine cervical laceration, Suicidal ideation, Productive cough, Lumbar spinal stenosis, Blood potassium abnormal, Blood glucose abnormal, Cholelithiasis, Presyncope, |
||||
| 20 | 26556872 |
US |
2 | |
Pneumonia, Chronic obstructive pulmonary disease, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE, ERGOCALCIFEROL, |
||||
| 21 | 26556879 |
GB |
79 | 2 |
Pneumonia, |
||||
SARILUMAB, |
||||
| 22 | 26556967 |
EU |
67 | 2 |
Acute kidney injury, Septic shock, Pneumonia, Viral infection, Bacterial infection, Leukopenia, Haematuria, Diarrhoea, Adenovirus infection, Campylobacter infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 23 | 26557029 |
JP |
2 | |
Neuromyelitis optica spectrum disorder, Pneumonia, |
||||
SATRALIZUMAB, |
||||
| 24 | 26557267 |
US |
||
Pneumonia, Product dose omission issue, Off label use, Respiratory syncytial virus infection, |
||||
LENALIDOMIDE, |
||||
| 25 | 26557640 |
CA |
52 | 2 |
Blood bilirubin increased, Bronchiectasis, Asthma-chronic obstructive pulmonary disease overlap syndrome, Hepatic enzyme increased, Total lung capacity increased, Schizophrenia, Oedema peripheral, Hypomania, Lung neoplasm malignant, Cardiac murmur, Nasal polyps, Chronic obstructive pulmonary disease, Rhinitis allergic, Cholelithiasis, Nausea, Off label use, Jaundice cholestatic, Sarcoidosis, Wheezing, Gastrooesophageal reflux disease, Hepatotoxicity, Vomiting, Pneumonia, Condition aggravated, Psychotic disorder, |
||||
FLUTICASONE PROPIONATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACLIDINIUM BROMIDE, ACLIDINIUM BROMIDE, ACLIDINIUM BROMIDE, TIPRANAVIR, TIPRANAVIR, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, CLONAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, GLYCOPYRROLATE, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, OLANZAPINE, OLANZAPINE, RISPERIDONE, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, TIOTROPIUM BROMIDE, CARBAMAZEPINE, CARBAMAZEPINE, TIPRANAVIR, IPRATROPIUM BROMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, MEPOLIZUMAB, MONTELUKAST, MOMETASONE FUROATE, MEPOLIZUMAB, CICLESONIDE, ALBUTEROL SULFATE, ALBUTEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OLANZAPINE, OLANZAPINE PAMOATE, LAMIVUDINE, LAMIVUDINE ORAL, DIPHENHYDRAMINE HYDROCHLORIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CALCIUM CARBONATE, ANTACID, CICLESONIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LACTULOSE, ABACAVIR SULFATE, ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, LITHIUM, LITHIUM BROMATUM, SERTRALINE HYDROCHLORIDE, ZINC OXIDE, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/LIGHT, ZINC OXIDE OINTMENT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/TAN, SKIN PROTECTANT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 NATURAL/MEDIUM, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 COOL/DEEP, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, |
||||
| 26 | 26557963 |
EU |
45 | 1 |
Gastrointestinal disorder, Empyema, Ileus paralytic, Pneumonia, Sepsis, Polyomavirus viraemia, Drug ineffective, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZATHIOPRINE, BASILIXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 27 | 26558082 |
US |
78 | 2 |
Pneumonia, |
||||
NATALIZUMAB, |
||||
| 28 | 26558279 |
US |
61 | 1 |
Pneumonia, |
||||
POMALIDOMIDE, |
||||
| 29 | 26558376 |
CN |
||
Leukopenia, Pancytopenia, Fatigue, Neutropenia, Decreased appetite, Thrombocytopenia, Vomiting, Nausea, Transaminases increased, Liver function test abnormal, Diarrhoea, Pneumonitis, Autoimmune thyroiditis, Rash, Procedural pain, Pneumonia, Anaemia, Wound complication, |
||||
ATEZOLIZUMAB, DURVALUMAB, ETOPOSIDE, CISPLATIN, CARBOPLATIN, |
||||
| 30 | 26558484 |
US |
||
Pneumonia, Respiratory syncytial virus infection, Off label use, |
||||
LENALIDOMIDE, |
||||
| 31 | 26558709 |
US |
64 | 1 |
Pneumonia, Eyelid disorder, |
||||
LENALIDOMIDE, |
||||
| 32 | 26558882 |
CA |
65 | 2 |
Pneumonia, Pain, Wheezing, Dyspnoea, Oedema, Nasal oedema, Malaise, Asthma, Cough, Respiratory tract infection, Drug hypersensitivity, Vomiting, Chest pain, |
||||
FLUTICASONE PROPIONATE, CALCIUM CARBONATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, ROSUVASTATIN, ROSUVASTATIN, ERGOCALCIFEROL, FLUTICASONE FUROATE, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, CEFADROXIL, POLYMYXIN B SULFATE, |
||||
| 33 | 26559063 |
US |
48 | 1 |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 34 | 26559077 |
US |
71 | |
Pneumonia, Asthma, Nasopharyngitis, Dermatitis atopic, |
||||
| 35 | 26559283 |
US |
||
Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 36 | 26559389 |
EU |
63 | 2 |
Influenza, Pneumonia, Anaphylactic shock, |
||||
| 37 | 26559430 |
EU |
63 | 2 |
Aphthous ulcer, Pneumonia, Rash, |
||||
PEMBROLIZUMAB, NEBIVOLOL HYDROCHLORIDE, CARBAMAZEPINE, |
||||
| 38 | 26559633 |
CN |
70 | 2 |
Disease progression, Myelosuppression, Pneumonia, Aspergillus infection, Influenza, |
||||
DOXORUBICIN, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, |
||||
| 39 | 26559655 |
US |
||
Pneumonia, |
||||
ACYCLOVIR, BIOTIN, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, GENTAMICIN SULFATE, LORAZEPAM, METHYLPREDNISOLONE, MINOXIDIL, PENICILLIN V POTASSIUM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ERGOCALCIFEROL, |
||||
| 40 | 26559688 |
KR |
70 | 2 |
Metastases to lung, Pneumonia, Electrocardiogram QT prolonged, Neutropenia, Pneumonitis, Fall, Musculoskeletal chest pain, Liver function test increased, Pyrexia, |
||||
LETROZOLE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, FAMOTIDINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, EPINASTINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE, |
||||
| 41 | 26559694 |
US |
71 | 2 |
Cardiomyopathy, Fall, Upper limb fracture, Pneumonia, Dyspnoea, |
||||
AMLODIPINE BESYLATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CARVEDILOL, FOLIC ACID, GLIPIZIDE, GLIPIZIDE-TABLETS, |
||||
| 42 | 26559697 |
US |
61 | 1 |
Pneumonia, Neutropenia, |
||||
MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE, |
||||
| 43 | 26559730 |
US |
72 | |
Pneumonia, Haemoptysis, Lethargy, Oedema peripheral, Peripheral swelling, Contusion, Nail discolouration, Product distribution issue, Dyspnoea exertional, Product dose omission issue, Headache, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 44 | 26559892 |
JP |
8 | 2 |
Pneumonia, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
| 45 | 26560080 |
US |
80 | 2 |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 46 | 26560117 |
US |
70 | 2 |
Pneumonia, |
||||
DUPILUMAB, |
||||
| 47 | 26560168 |
US |
84 | 1 |
Gallbladder operation, Anxiety, Pneumonia, Pneumonia, Diarrhoea, Dysuria, Dyspnoea exertional, Pollakiuria, Rhinorrhoea, Claustrophobia, Increased need for sleep, Paranasal sinus hypersecretion, Fatigue, Laziness, Lethargy, Diarrhoea, Oxygen saturation decreased, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 48 | 26560577 |
JP |
||
Pneumonia, Infective exacerbation of asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 49 | 26560742 |
AR |
17 | 1 |
Pneumonia, |
||||
| 50 | 26560948 |
EU |
64 | 1 |
Pneumonia, |
||||
| 51 | 26560950 |
US |
2 | |
Pneumonia, Product dose omission issue, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 52 | 26561069 |
EU |
||
Lactic acidosis, Pneumonia, |
||||
EMPAGLIFLOZIN, |
||||
| 53 | 26561257 |
GB |
77 | 1 |
Abscess, Back pain, Hypophagia, Respiratory syncytial virus infection, Influenza, Pneumonia, Mass, Weight decreased, |
||||
RITUXIMAB, DOXORUBICIN, POLATUZUMAB VEDOTIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, BISOPROLOL FUMARATE, RAMIPRIL, |
||||
| 54 | 26561320 |
US |
69 | 2 |
Pneumonia, Inappropriate schedule of product administration, Injection site rash, Injection site pruritus, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 55 | 26561364 |
CA |
50 | 2 |
Pneumonia, Off label use, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
| 56 | 26561501 |
CA |
1 | |
Dyspnoea, Cardiac failure congestive, Pneumonia, |
||||
ECULIZUMAB, ECULIZUMAB, |
||||
| 57 | 26561503 |
JP |
||
Renal cancer, Pneumonia, Anaemia, Cellulitis, |
||||
UPADACITINIB, |
||||
| 58 | 26561527 |
59 | ||
Shoulder arthroplasty, Pneumonia, Rib fracture, Influenza, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 59 | 26561565 |
US |
33 | |
Pneumonia, Product use issue, |
||||
| 60 | 26561615 |
CA |
65 | 2 |
Pneumonia, Drug hypersensitivity, Vomiting, Wheezing, Dyspnoea, Asthma, Oedema, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, AMINOPHYLLINE, AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, OMALIZUMAB, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, FLUTICASONE PROPIONATE, |
||||
| 61 | 26565743 |
66 | 2 | |
Pneumonia, Fall, Hip fracture, |
||||
USTEKINUMAB, |
||||
| 62 | 26569902 |
64 | 1 | |
Pneumonia, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PATIROMER, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, METOPROLOL TARTRATE, METOPROLOL, EMPAGLIFLOZIN, MAGNESIUM OXIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, PREDNISONE, |
||||
| 63 | 26570022 |
1 | ||
Therapy interrupted, Pneumonia, Thrombosis, Pulmonary embolism, |
||||
LENALIDOMIDE, |
||||
| 64 | 26570023 |
71 | 1 | |
Dyspnoea, Hypoxia, Chest discomfort, Pneumonia, Pneumonitis, Cardiac failure congestive, Acute respiratory failure, |
||||
CARBOPLATIN, |
||||
| 65 | 26570139 |
1 | ||
Pneumonia, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, |
||||
| 66 | 26550008 |
EU |
2 | |
Pneumonia, Erythema, Dry mouth, Cough, Musculoskeletal chest pain, Body temperature increased, |
||||
| 67 | 26550104 |
CL |
35 | 2 |
Pneumonia, |
||||
GOLIMUMAB, |
||||
| 68 | 26550287 |
US |
2 | |
Pneumonia, Chest discomfort, Dyspnoea, Wheezing, Cough, Loss of personal independence in daily activities, Exercise tolerance decreased, Asthma, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 69 | 26550299 |
JP |
||
Pneumonia, |
||||
MEPOLIZUMAB, |
||||
| 70 | 26550316 |
PE |
75 | |
Pneumonia, Respiratory failure, |
||||
NIVOLUMAB, |
||||
| 71 | 26550412 |
EU |
61 | 1 |
Pneumonia, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, DOCETAXEL, DOCETAXEL ANHYDROUS, OXALIPLATIN, |
||||
| 72 | 26550642 |
CA |
2 | |
Pneumonia, Physical deconditioning, Platelet count decreased, |
||||
IXAZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CALCIUM CARBONATE, ANTACID, CANDESARTAN, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACYCLOVIR, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, SENNOSIDES, SENNA LEAF, SENNA, WARFARIN, |
||||
| 73 | 26550717 |
CA |
76 | 1 |
Pneumonia, |
||||
VEDOLIZUMAB, EZETIMIBE, METOPROLOL TARTRATE, METOPROLOL, AMLODIPINE, IRBESARTAN, LANSOPRAZOLE, |
||||
| 74 | 26550878 |
60 | ||
Pneumonia, Stomatitis, Oral candidiasis, Therapeutic response shortened, Drug ineffective, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 75 | 26551038 |
US |
77 | 1 |
Pneumonia, Off label use, Bronchitis, Fatigue, |
||||
INTERFERON GAMMA-1B, |
||||
| 76 | 26551083 |
CO |
83 | 2 |
Pneumonia, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 77 | 26551110 |
US |
1 | |
Pneumonia, Bacterial sepsis, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, PREDNISONE, PREDNISONE, |
||||
| 78 | 26551179 |
EU |
||
Herpes zoster, Urinary tract infection, Impetigo, Respiratory failure, Pneumonia, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHOTREXATE, METHOTREXATE SODIUM, AZATHIOPRINE, |
||||
| 79 | 26551303 |
US |
53 | 2 |
Pneumonia, Dyspnoea, Nocturnal dyspnoea, Sleep disorder, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 80 | 26551306 |
US |
71 | 2 |
Pneumonia, Lung abscess, Respiratory tract infection, Influenza, Rhinovirus infection, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 81 | 26551324 |
US |
41 | 1 |
Pneumonia, Cough, Dyspnoea, Pyrexia, Viral infection, |
||||
DUPILUMAB, |
||||
| 82 | 26551454 |
JP |
70 | 1 |
Pleural effusion, Enterocolitis bacterial, Embolism venous, Febrile neutropenia, Neutrophil count decreased, Pneumonia, Pneumonia, Nausea, Constipation, Hypoalbuminaemia, Oedema peripheral, Infusion related reaction, Nausea, Nausea, Platelet count decreased, Nausea, Peripheral sensory neuropathy, Decreased appetite, Taste disorder, Infusion related reaction, |
||||
ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, CAPECITABINE, OXALIPLATIN, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), RAMUCIRUMAB, OLANZAPINE, SENNOSIDES, FUROSEMIDE, SPIRONOLACTONE, EDOXABAN TOSYLATE, EDOXABAN TOSYLATE, SPIRONOLACTONE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, FILGRASTIM, FILGRASTIM, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AMPICILLIN SODIUM AND SULBACTAM SODIUM, FUROSEMIDE, FUROSEMIDE, |
||||
| 83 | 26551511 |
JP |
9 | 2 |
Pneumonia, Neutropenia, |
||||
ZONGERTINIB, ZONGERTINIB, |
||||
| 84 | 26551622 |
US |
76 | 2 |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 85 | 26551631 |
US |
27 | 1 |
Pneumonia, |
||||
OSILODROSTAT, OSILODROSTAT, |
||||
| 86 | 26551635 |
VN |
1 | |
Myelosuppression, Pneumonia, Respiratory distress, Condition aggravated, Anaemia, Otitis media, Thrombocytopenia, Off label use, |
||||
GANCICLOVIR SODIUM, GANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, GENTAMICIN, GENTAMICIN SULFATE, CEFOTAXIME, CEFOTAXIME INJECTION, ACYCLOVIR, MEROPENEM, |
||||
| 87 | 26551733 |
CA |
65 | 2 |
Abdominal pain, Aortic aneurysm, Arterial occlusive disease, Back pain, Brain operation, Burning sensation, Cerebrovascular accident, Contusion, Diabetes mellitus, Diarrhoea, Drug ineffective, Gait disturbance, Infection, Nasopharyngitis, Pain in extremity, Parathyroid disorder, Peripheral artery occlusion, Peripheral swelling, Pneumonia, Product complaint, Product dose omission issue, Raynaud^s phenomenon, Respiratory syncytial virus infection, Neuralgia, Rosacea, Stress, Systemic lupus erythematosus, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BELIMUMAB, BELIMUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 88 | 26551776 |
US |
71 | 2 |
Pneumonia, Urinary tract infection, Eye infection, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 89 | 26551808 |
71 | 2 | |
Pneumonia, Myelosuppression, Leukopenia, Thrombocytopenia, Neoplasm progression, Aspergillus infection, Influenza, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXORUBICIN, DOXORUBICIN, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 90 | 26551852 |
US |
2 | |
Pneumonia, Oxygen saturation decreased, Oropharyngeal pain, Pulmonary pain, Dyspnoea, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 91 | 26551925 |
US |
56 | 1 |
Pneumonia, Pulmonary thrombosis, |
||||
LENALIDOMIDE, |
||||
| 92 | 26552068 |
CA |
1 | |
Pneumonia, Sensation of foreign body, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 93 | 26552137 |
CA |
67 | 2 |
Pneumonia, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, ESTRADIOL, EPINEPHRINE, ADRENALINUM, HYDROCORTISONE, LEVOTHYROXINE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, LORATADINE, LORATADINE ORAL, CELECOXIB, ATORVASTATIN CALCIUM, PROGESTERONE, ALENDRONATE SODIUM, BUDESONIDE, CETIRIZINE HCL, CETIRIZINE, DICYCLOMINE HYDROCHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 94 | 26552176 |
US |
71 | 2 |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 95 | 26552310 |
CA |
65 | 2 |
Pneumonia, Drug hypersensitivity, Oedema, Wheezing, Dyspnoea, Vomiting, Asthma, |
||||
FLUTICASONE PROPIONATE, AMINOPHYLLINE, CLONAZEPAM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN, MONTELUKAST SODIUM, CIPROFLOXACIN HYDROCHLORIDE, OMALIZUMAB, PREDNISOLONE SODIUM PHOSPHATE, RITUXIMAB, RITUXIMAB, ROSUVASTATIN CALCIUM, RISEDRONATE SODIUM, TRAMADOL HYDROCHLORIDE, RISEDRONATE SODIUM, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 96 | 26552516 |
EU |
54 | 1 |
Lupus nephritis, Disease recurrence, Pneumonia, Multiple organ dysfunction syndrome, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOSPORINE, |
||||
| 97 | 26552543 |
US |
83 | 2 |
Pneumonia, Headache, Fatigue, Diarrhoea, Flatulence, Gastrointestinal pain, Asthenia, Balance disorder, |
||||
NERANDOMILAST, |
||||
| 98 | 26552546 |
CO |
69 | 2 |
Pneumonia, Paralysis, Fall, Head injury, Loss of consciousness, Osteomyelitis, Vertigo, Seizure, |
||||
ROMOSOZUMAB-AQQG, ROMOSOZUMAB-AQQG, ROMOSOZUMAB-AQQG, |
||||
| 99 | 26552624 |
CA |
2 | |
Pneumonia, |
||||
BENRALIZUMAB, BENRALIZUMAB, ALBUTEROL SULFATE, GLYCOPYRROLATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, PREDNISONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 100 | 26553136 |
CA |
56 | 2 |
Transfusion, Pneumonia, Fatigue, Weight decreased, Malaise, Coma, Memory impairment, Neuralgia, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28